Akorn Inc (NASDAQ:AKRX) on Focus After Report of Less Shorts

The stock of Akorn Inc (NASDAQ:AKRX) registered a decrease of 16.36% in short interest. AKRX’s total short interest was 7.30 million shares in December as published by FINRA. Its down 16.36% from 8.73 million shares, reported previously. With 2.50M shares average volume, it will take short sellers 3 days to cover their AKRX’s short positions. The short interest to Akorn Inc’s float is 7.78%.

The stock decreased 3.81% or $0.17 during the last trading session, reaching $4.29. About 3.39M shares traded. Akorn, Inc. (NASDAQ:AKRX) has declined 86.27% since December 11, 2017 and is downtrending. It has underperformed by 86.27% the S&P500.

Akorn, Inc., a specialty generic pharmaceutical company, develops, makes, and markets specialized generic and branded pharmaceuticals, over-the-counter drug products, and animal health products in the United States and internationally. The company has market cap of $538.36 million. The firm operates in two divisions, Prescription Pharmaceuticals and Consumer Health. It currently has negative earnings. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics.

Akorn, Inc. (NASDAQ:AKRX) Ratings Coverage

Among 2 analysts covering Akorn (NASDAQ:AKRX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Akorn had 2 analyst reports since October 17, 2018 according to SRatingsIntel. The stock of Akorn, Inc. (NASDAQ:AKRX) has “Overweight” rating given on Wednesday, October 17 by PiperJaffray. On Tuesday, November 27 the stock rating was maintained by Piper Jaffray with “Buy”.

More notable recent Akorn, Inc. (NASDAQ:AKRX) news were published by: Seekingalpha.com which released: “Marinus Pharmaceuticals and CorMedix among healthcare gainers; MiMedx Group leads the losers – Seeking Alpha” on December 06, 2018, also Benzinga.com with their article: “48 Biggest Movers From Friday – Benzinga” published on December 10, 2018, Streetinsider.com published: “Akorn (AKRX) CEO to Leave After Negative Delaware Supreme Court Decision – StreetInsider.com” on December 10, 2018. More interesting news about Akorn, Inc. (NASDAQ:AKRX) were released by: Nasdaq.com and their article: “Here’s Why Akorn Pharmaceuticals Is Sinking Today – Nasdaq” published on December 06, 2018 as well as Seekingalpha.com‘s news article titled: “Microcaps tops midday movers – Seeking Alpha” with publication date: December 07, 2018.

Akorn, Inc. (NASDAQ:AKRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.